CDKN2A novel mutation in a patient from a melanoma-prone family

Melanoma Research

Volumn 11, Issue 5, 2001, Pages 447-449

  Grammatico, P ^a   Binni, F ^a   Eibenschutz, L ^b   De Bernardo, C ^a   Grammatico, B ^a   Rinaldi, R ^a   De Simone, P ^b   Catricala C ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

CDKN2A; Deletion; Familial melanoma

Indexed keywords

ADULT; ARTICLE; CASE REPORT; FAMILIAL CANCER; FEMALE; GENE DELETION; GENE LOCUS; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HETERODUPLEX ANALYSIS; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STOP CODON;

ADULT; BASE SEQUENCE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DATABASES, NUCLEIC ACID; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETERODUPLEX ANALYSIS; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUTATION; PEDIGREE; SKIN NEOPLASMS;

EID: 0034777020     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200110000-00002     Document Type: Article

References (10)

1. Prognostic factors in metastatic melanoma
2. Genetic aspects of cutaneous malignant melanoma
3. Germline p16 mutations in familial melanoma
4. INK4Amutation and protein dysfunction in a family with inherited melanoma
5. Novel germline p16 mutation in familial melanoma in Southern Sweden
6. Mutation testing in melanoma families INK4A, CDK4 and INK4D
7. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
8. INK4A in human cancer
9. ink4 allele
10. CDKN2A mutation in a non-FAMMM kindred with cancer at multiple sites results in a functionally abnormal protein